GCUFBioinfo: Drug Lead Optimization.drug discovery screening

This is featured post 1 title

Replace these every slider sentences with your featured post descriptions.Go to Blogger edit html and find these sentences.Now replace these with your own descriptions.This theme is Bloggerized by Lasantha - Premiumbloggertemplates.com.

This is featured post 2 title

This is featured post 3 title

This is featured post 4 title

This is featured post 5 title

Showing posts with label Drug Lead Optimization.drug discovery screening. Show all posts

Friday, October 29, 2010

Steps Involved in Drug Designing

3:15 AM

GCbioinfo

Drug designing steps were usually divided into steps as follows:

I. LIGAND PREPARATION

II. RECEPTOR PREPARATION

III. DOCKING

IV. BINDING AFFINITY STUDIES

Read more »

Friday, August 20, 2010

Drug Lead Optimization.

1:28 AM

GCbioinfo

Drug Lead Optimization. When a promising lead candidate has been found in a drug discovery program, the next step (a very long and expensive step!) is to optimize the structure and properties of the potential drug. This usually involves a series of modifications to the primary structure (scaffold) and secondary structure (moieties) of the compound. This process can be enhanced using software tools that explore related compounds (bioisosteres) to the lead candidate. OpenEye’s WABE is one such tool. Lead optimization tools such as WABE offer a rational approach to drug design that can reduce the time and expense of searching for related compounds.

Read more »